Patent · US Active

TRPV4 antagonists

US8658636B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 23, 2011
Grant dateFeb 25, 2014
Priority date—
Expiry dateJun 20, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to quinoline analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.